Major study highlights promise of digital technology in improving hypertension care across sub-Saharan Africa
13 May 2026
A major international study published today in BMJ Public Health has found that a digitally enabled healthcare programme was associated with significant improvements in blood pressure control among people living with hypertension across sub-Saharan Africa.
Professor Adrian Hill selected as a finalist for the European Inventor Award 2026
12 May 2026
The European Patent Office has named Professor Adrian Hill, Lakshmi Mittal Professor of Vaccinology and Director of the Jenner Institute at the University of Oxford, a finalist for the European Inventor Award 2026 for work leading to the R21/Matrix-M malaria vaccine, a major advance in efforts to reduce the global burden of malaria.
Solidarity: the word everyone uses, but few practise
7 May 2026
What does solidarity actually demand of global health when the system itself is under strain? This question gave the Global Health Solidarity Project’s 2026 Open Forum urgency, edge and relevance.
New study improves early detection of life-threatening infection in children across South and South East Asia
6 May 2026
A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.
New study highlights promising non-invasive approach to endometriosis diagnosis and monitoring
29 April 2026
A new Oxford-led study highlights the potential of a molecular imaging agent used alongside non-invasive scanning to improve the diagnosis and monitoring of endometriosis - a condition affecting an estimated 190 million women worldwide.
New rabies vaccine could provide protection for adults and children with a single dose
29 April 2026
A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.
Expert Comment: World Malaria Day 2026 - Malaria vs the Data Collective
27 April 2026
Malaria is one of the world’s oldest known diseases, but it is a modern disease too - it continues to kill roughly 600,000 people each year. Most of these people are children, living in Sub-Saharan Africa.
University of Oxford and Serum Institute of India agree licence to advance the next-generation multi-stage malaria vaccine candidate component
25 April 2026
The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), a Cyrus Poonawalla group company and the world’s largest vaccine manufacturer by volume, have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.
From Kilifi to the World: Rethinking Malaria Control Through Three Decades of Research
24 April 2026
Since 1995, the KEMRI–Wellcome Trust Research Programme has quietly reshaped the global fight against malaria, not through a single breakthrough, but through a sustained commitment to evidence, context and people. Its work offers a powerful lesson: defeating malaria is not just about tools, but about understanding systems, adapting strategies and investing in local science. This is a thought leadership piece by Professor Isabella Oyier, Head of Bioscience, KEMRI-Wellcome
Innovative housing design cools homes, saves lives in Africa
22 April 2026
New housing designs that reduce indoor temperatures and improve ventilation can help cut infectious disease and improve health outcomes in sub-Saharan Africa, according to new Oxford-led research.
OUCRU joins WHO Coronavirus Network
16 April 2026
Researchers at Oxford University Clinical Research Unit (OUCRU) are part of a new WHO network aimed at improving global coronavirus surveillance and strengthening preparedness for future pandemics.
Global series highlights innovations and impact in post-pregnancy contraception
9 April 2026
A collection of seven articles in Best Practice & Research Clinical Obstetrics & Gynaecology, led by Visiting Editor Anita Makins, brings together global expertise on post-pregnancy contraception - an area critical to improving maternal and newborn health outcomes worldwide.
Reimagining community mental health in Kenya through the 'Nyumba Kumi' model
8 April 2026
Community-based approaches like the Nyumba Kumi model highlight how locally embedded partnerships can address mental health challenges in low-resource settings.
What counts as ‘fake’ in global health? April Fakes Day 2026
30 March 2026
How boundaries between ‘real’ and ‘fake’ are defined, contested and governed in global health.
Collaboration with the Nepal Public Health Foundation explores maternal health and epilepsy
26 March 2026
A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.
Blood test may improve survival of childhood cancer in Africa
23 March 2026
A simple blood test could speed up diagnosis and improve outcomes for children with Africa’s most common childhood cancer.
Championing Ethical Research: Dorcas Kamuya on Community, Science, and Women in Leadership
23 March 2026
Dorcas Kamuya’s journey highlights the impact of ethical, community-centred research. From rural Kenya to scientific leadership, she champions equity, mentorship, and inclusive research practices. Her work ensures that science respects community voices while advancing health systems, inspiring the next generation of women in research.
Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate
17 March 2026
The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate. Professor Brian Angus is Chief Investigator of the trial.
Nuffield Department of Primary Care Health Sciences designated a WHO Collaborating Centre on Primary Health Care
12 March 2026
The World Health Organization (WHO) has designated the Nuffield Department of Primary Care Health Sciences at the University of Oxford as the WHO Collaborating Centre on Primary Health Care.
From Factory Worker to Infectious Diseases Scientist: The Story of OUCRU Indonesia’s Suwarti
10 March 2026
OUCRU Indonesia highlights the remarkable journey of Dr Suwarti, a scientist who rose from factory work to infectious diseases research. Through determination, education, and mentorship, Suwarti built a scientific career addressing critical public health challenges. Her story reflects OUCRU’s commitment to developing local research talent and expanding scientific opportunity in Indonesia.